Clinical Trials Committee – 2017 Meeting Dates & Deadlines
The HREBA – Clinical Trials Committee (CTC) only accepts new submissions through IRISS. The CTC office must receive all new study applications together with all supporting documents before 4 pm on the submission date.
This is the current schedule:
|Meeting Date||Submission Deadline|
|(Third Friday of the month except where indicated*)||(Fourth Tuesday prior to meeting except where indicated*)|
|20 January 2017||20 December 2016|
|10 February 2017 *||24 January 2017|
|17 March 2017||21 February 2017|
|21 April 2017||28 March 2017|
|12 May 2017||25 April 2017|
|16 June 2017||23 May 2017|
|21 July 2017||27 June 2017|
|18 August 2017||25 July 2017|
|15 September 2017||22 August 2017|
|20 October 2017||26 September 2017|
|17 November 2017||24 October 2017|
|15 December 2017||21 November 2017 *|
|19 January 2018||19 December 2017 *|
A print version is available here.
After meeting, the CTC will notify Investigators of the results of the review within one week.
Note: Effective June 15, 2001, in accordance with Section 50(4) of The Health Information Act, the CTC provides to the Information and Privacy Commissioner, copies of approvals granted by the Committee, including final letters of approval, annual re-approvals and notification of termination/completion of studies.
2017 Fees – Effective July 1, 2017
The applicable fees listed below will be invoiced to the investigator for industry sponsored studies only. Please do not send in the review fee until you receive an invoice from Alberta Innovates. GST will be added if applicable.
This applies only to industry sponsored studies received by HREBA after July 1st, 2017. Regardless of their initial approval date, these studies will not be charged any additional fees for changes e.g. modifications, annual renewals, closures after July 1st, 2017.